Lytic activity against primary AML cells is stimulated in vitro by an autologous whole cell vaccine expressing IL-2 and CD80 (2009)

First Author: Hardwick N
Attributed to:  BRIC: Packaging cell lines for inherently manufacturable viral vectors funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00262-009-0756-x

PubMed Identifier: 19711075

Publication URI: http://europepmc.org/abstract/MED/19711075

Type: Journal Article/Review

Parent Publication: Cancer Immunology, Immunotherapy

Issue: 3

ISSN: 0340-7004